At two weeks of the recovery phase, MCP-treated mice demonstrated reduced Gal-3, with decreased renal fibrosis, macrophages, pro-inflammatory cytokine expression, and apoptosis. This evidence concerns the gene LGALS3 and renal fibrosis.